Source:
Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2021 Sep; Vol. 36 (7), pp. 568-578. Date of Electronic Publication: 2020 Jul 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic
Authors : Song YS; 1 Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine , Seoul, Republic of Korea.; Park HS
Source:
Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2017 Oct; Vol. 32 (8), pp. 288-296.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:
Authors : Filippi L; Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Rome Tor Vergata, Rome, Italy.; Santoni R
Source:
Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2009 Apr; Vol. 24 (2), pp. 229-35.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:
Source:
Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2006 Feb; Vol. 21 (1), pp. 41-8.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:
Source:
Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2011 Oct; Vol. 26 (5), pp. 557-63. Date of Electronic Publication: 2011 Sep 01.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic